Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Ibrutinib,"Waldenstroms Macroglobulinaemia, relapsed within 5 years of treatment,  under 55 years",Ibrutinib (Imbruvica),,Community,Oncology Agents and Immunosuppressants
